The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Inactivated Split Influenza Vaccine, in Volunteers Who Are Over 60 Years Old

NCT05089123 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

320

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Flu-M [Inactivated split influenza vaccine]
BIOLOGICAL: Inactivated Split Influenza Vaccine

Sponsor

St. Petersburg Research Institute of Vaccines and Sera